Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 11:43 am Sale | 2022-12-31 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 2,904,826 17.250% | -1 (-0.00%) | Filing History |
| 2023-01-31 1:51 pm Sale | 2022-12-31 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 850,197 5.050% | -167 (-0.02%) | Filing History |
| 2022-10-11 09:03 am Purchase | 2022-10-07 | 13G | Regulus Therapeutics Inc. RGLS | FMR LLC | 2,195,000 14.998% | 2,195,000 (New Position) | Filing History |
| 2022-05-16 2:35 pm Purchase | 2022-04-30 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 2,904,827 19.900% | 2,904,827 (New Position) | Filing History |
| 2022-02-14 4:33 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Point72 Asset Management L.P. | 241,158 1.600% | -321,544 (-57.14%) | Filing History |
| 2022-02-14 2:30 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Altium Capital Management LP | 172,978 2.100% | -150,000 (-46.44%) | Filing History |
| 2022-02-14 2:15 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | EcoR1 Capital LLC | 253,897 1.700% | -111,111 (-30.44%) | Filing History |
| 2022-02-14 1:05 pm Purchase | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | BIOTECHNOLOGY VALUE FUND L P | 966,124 9.990% | 261,077 (+37.03%) | Filing History |
| 2022-02-02 09:55 am Unchanged | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 850,364 5.830% | 0 (Unchanged) | Filing History |
| 2022-01-04 12:37 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 850,364 5.830% | -1,560 (-0.18%) | Filing History |
| 2021-12-09 2:58 pm Purchase | 2021-11-30 | 13D | Regulus Therapeutics Inc. RGLS | Growth Equity Opportunities V LLC | 1,458,252 9.990% | 1,253,007 (+610.49%) | Filing History |
| 2021-03-08 11:05 am Purchase | 2021-02-28 | 13G | Regulus Therapeutics Inc. RGLS | VICTORY CAPITAL MANAGEMENT INC | 851,924 12.730% | 851,924 (New Position) | Filing History |
| 2021-02-12 7:23 pm Purchase | 2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS | BIOTECHNOLOGY VALUE FUND L P | 705,046 9.990% | 495,376 (+236.26%) | Filing History |
| 2021-02-12 5:11 pm Unchanged | 2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Altium Capital Management LP | 322,978 6.800% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:15 pm Purchase | 2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS | EcoR1 Capital LLC | 365,008 5.400% | 132,744 (+57.15%) | Filing History |
| 2020-12-09 5:13 pm Purchase | 2020-12-04 | 13G | Regulus Therapeutics Inc. RGLS | Point72 Asset Management L.P. | 562,701 8.500% | 562,701 (New Position) | Filing History |